Qube Research & Technologies LTD Gossamer Bio, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 181,638 shares of GOSS stock, worth $174,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,638
Previous 659,685
72.47%
Holding current value
$174,372
Previous $778,000
79.05%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GOSS
# of Institutions
101Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$17.4 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$12.8 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$11.3 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.82 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.73 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $90.2M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...